Ligand validation:3QAP

LFA: EICOSANE

LFA is a Ligand Of Interest in 3QAP designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Model completeness	Average occupancy
3QAP_LFA_A_247	38%	81%	0.09	0.927	0.39	0.43	-	-	0	25%	0.25
3QAP_LFA_A_248	35%	81%	0.1	0.904	0.34	0.48	-	-	0	35%	0.35
3QAP_LFA_A_254	27%	76%	0.161	0.84	0.37	0.57	-	-	0	80%	0.8
3QAP_LFA_A_267	26%	76%	0.186	0.826	0.39	0.53	-	-	3	100%	1
3QAP_LFA_A_251	21%	77%	0.143	0.786	0.4	0.51	-	-	0	80%	0.8
3QAP_LFA_A_244	16%	76%	0.155	0.815	0.42	0.51	-	-	0	50%	0.5
3QAP_LFA_A_243	15%	86%	0.156	0.843	0.4	0.33	-	-	0	30%	0.3
3QAP_LFA_A_250	15%	81%	0.161	0.815	0.39	0.43	-	-	0	45%	0.45
3QAP_LFA_A_246	14%	77%	0.15	0.806	0.36	0.54	-	-	0	40%	0.4
3QAP_LFA_A_245	12%	86%	0.162	0.815	0.39	0.33	-	-	1	30%	0.3
3QAP_LFA_A_264	12%	79%	0.193	0.817	0.34	0.51	-	-	0	45%	0.45
3QAP_LFA_A_249	11%	81%	0.21	0.859	0.36	0.45	-	-	0	25%	0.25
3QAP_LFA_A_271	9%	76%	0.197	0.687	0.38	0.56	-	-	0	100%	1
3QAP_LFA_A_261	9%	75%	0.184	0.722	0.35	0.61	-	-	5	70%	0.7
3QAP_LFA_A_256	8%	85%	0.157	0.767	0.39	0.35	-	-	0	25%	0.25
3QAP_LFA_A_258	8%	85%	0.175	0.776	0.39	0.36	-	-	0	30%	0.3
3QAP_LFA_A_268	8%	80%	0.162	0.748	0.38	0.46	-	-	0	35%	0.35
3QAP_LFA_A_242	7%	76%	0.216	0.761	0.42	0.52	-	-	0	50%	0.5
3QAP_LFA_A_255	7%	77%	0.219	0.723	0.36	0.55	-	-	3	70%	0.7
3QAP_LFA_A_252	7%	75%	0.213	0.733	0.34	0.61	-	-	3	60%	0.6
3QAP_LFA_A_265	6%	78%	0.224	0.764	0.41	0.47	-	-	0	40%	0.4
3QAP_LFA_A_272	4%	79%	0.206	0.655	0.4	0.45	-	-	0	60%	0.6
3QAP_LFA_A_266	3%	78%	0.246	0.654	0.41	0.47	-	-	0	50%	0.5
3QAP_LFA_A_270	2%	72%	0.368	0.755	0.44	0.62	-	-	0	20%	0.2
3QAP_LFA_A_269	1%	71%	0.239	0.592	0.48	0.62	-	-	0	20%	0.2
3QAP_LFA_A_263	1%	78%	0.219	0.504	0.39	0.48	-	-	0	50%	0.5
3QAP_LFA_A_259	1%	72%	0.315	0.604	0.45	0.6	-	-	1	20%	0.2
3QAP_LFA_A_262	1%	85%	0.231	0.447	0.4	0.34	-	-	0	30%	0.3
3QAP_LFA_A_253	0%	85%	0.403	0.494	0.41	0.33	-	-	0	30%	0.3
5JJE_LFA_A_310	38%	83%	0.126	0.861	0.27	0.51	-	-	0	80%	0.8
5JJJ_LFA_A_309	33%	77%	0.187	0.956	0.29	0.6	-	-	1	50%	0.5
3QDC_LFA_A_248	22%	81%	0.138	0.872	0.34	0.48	-	-	0	35%	19.25
4GYC_LFA_A_306	22%	73%	0.197	0.885	0.3	0.73	-	-	0	60%	0.6
5JJF_LFA_A_308	7%	80%	0.275	0.767	0.31	0.52	-	-	6	80%	0.8
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	100%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	5	75%	0.75
8QLF_LFA_A_408	55%	100%	0.083	0.933	0.1	0.06	-	-	1	55%	0.55
6RF6_LFA_A_307	50%	79%	0.101	0.904	0.23	0.62	-	-	0	70%	0.7
4HYJ_LFA_B_302	48%	74%	0.164	0.962	0.2	0.79	-	-	1	70%	0.7

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.

Prepare Data

Validate Data

Deposit Data

Help and Resources

3QAP

LFA: EICOSANE

LFA is a Ligand Of Interest in 3QAP designated by the RCSB